Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Matrix Biol. 2009 Aug 29;29(1):51–62. doi: 10.1016/j.matbio.2009.08.004

Table 2.

PEG and PEG-ChS Hydrogel Formulations and Their Resulting Properties

Hydrogel PEGDMa (w/w) % ChS-MAb (w/w) % [DB](M)c qd Ke (kPa)
PEG-only 100 0 0.065 9.6 ± 0.3 46 ± 5
20% ChS 80 20 0.061 11.1 ± 0.3*** 78 ± 8*
40% ChS 60 40 0.058 12.9 ± 0.2***, # 70 ± 3*
a

Poly(ethylene glycol) dimethacrylate (PEGDM) macromer concentration prior to polymerization;

b

Methacrylated chondroitin sulfate (ChS-MA) macromer concentration prior to polymerization;

c

Total double bond concentration ([DB]) in the macromer solution prior to polymerization based on ChS-MA (~48,700g/mol) (Bryant et. al., 2004b) substituted with 23 methacrylates per ChS molecule as determined by NMR and PEGDM (3000 g/mol);

d

Mass Swelling Ratio (q);

e

Tangent Compressive Modulus (K);

*

p<0.05,

***

p<0.001 compared to PEG-only gel;

#

p<0.001 compared to PEG-ChS gels (80:20).